Investor Type | Firm |
Industries | BioTech • Medical Devices (& Hospital Services) • Life Science |
Thuja Capital Management is a venture capital firm rooted in Utrecht, Netherlands, specializing in the healthcare sector with a focus on medical devices, diagnostics, therapeutics, medical food, and food supplements. They have a dedicated approach to investing in healthcare innovation from start-up to scale-up phase. The firm holds a particular interest in healthcare ventures that have a lasting impact on patients and society. Their investment thesis is built on supporting daring entrepreneurs with paradigm-shifting ideas and helping to start, build, and accelerate ventures through tranched investments that balance risk and return. Thuja Capital aims to create sustainable value by aiding the development of novel therapies in areas with high unmet medical needs. Their strategy includes investments in Biotech, Medical Devices (& Hospital Services), and Life Science industries with a geographical focus on the Benelux region while serving Europe at large. Thuja is also committed to Environmental, Social, and Governance (ESG) principles, actively contributing to the EU Life Sciences ESG Knowledge Project. They are involved in guiding healthcare ventures with their Impact & ESG Committee, ensuring that impact-driven approaches are entrenched within the firm's portfolio companies. They have a varied portfolio of active investments, and they are dedicated to growth and learning, as evidenced by their participation in industry events and news. Their team comprises Investment Management professionals, an Advisory Board, and Operational Partners who collectively have extensive experience in the healthcare venture sector.